Dynamic monitoring card for anti-tumor injection drugs
By designing a dynamic monitoring card for anti-tumor injectable drugs, the problem of inaccurate injection site recording by nurses during drug administration was solved, achieving efficient and safe injection management, reducing adverse reactions and errors, and improving the quality of nursing care and patients' trust.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2025-02-18
- Publication Date
- 2026-03-27
AI Technical Summary
In existing technologies, nurses face problems such as inaccurate and easily confused injection site records when administering anti-tumor drugs, leading to medication errors and subcutaneous induration. Furthermore, traditional paper records are prone to loss or fading, affecting the efficiency and safety of nursing work.
Design a dynamic monitoring card for injectable antitumor drugs, including a molded human body contour part, a pressable injection point protrusion, and an injection process recording protrusion. It has a patient information card insertion slot and an injection date recording part. It is made of integrated molding and elastic plastic material, and has a fluorescent layer, a waterproof membrane layer, and a hanging hole or magnet design to provide intuitive medication guidance and recording functions.
It improves the accuracy of injection sites and the reliability of records, reduces the risk of medication errors, reduces subcutaneous induration and adverse skin reactions, improves the efficiency and safety of nursing work, and extends the service life of monitoring cards.
Smart Images
Figure CN224039717U_ABST
Abstract
Description
TECHNICAL FIELD
[0001] The utility model belongs to nursing technical field, especially relate to a kind of antitumor injection class drug dynamic monitoring card. BACKGROUND
[0002] In the treatment field of hematological tumor, the complexity of patient's condition and the diversity of treatment regimen put forward very high requirements for clinical nursing work.Antitumor drugs, as the key means of treatment, correct administration not only concerns the personal safety of patients, but also directly affects the therapeutic effect of drugs and the control of disease progression.Currently, a variety of antitumor drugs are used in hematology department, among which many chemotherapy drugs, such as azacitidine and bortezomib, are administered by subcutaneous injection.
[0003] Azacitidine is a chemotherapy drug for treating acute myeloid leukemia, and its treatment regimen is usually 7 days or 9 days as a treatment cycle, 4ml each time, which needs to be injected in two parts, 2ml for each part. Bortezomib is a chemotherapy drug for treating multiple myeloma, which is injected on the 1st, 4th, 8th and 11th day according to a specific administration regimen, a total of 4 injections in a cycle, and the injection site is around the navel.
[0004] However, in clinical practice, nurses face many challenges in the process of administration. Traditionally, nurses use pens to mark on ordinary paper version of human injection site marking chart to record the injection of patients, but this way has many disadvantages. Paper is easy to lose or break, records may become blurred, which brings inconvenience to the checking work of nurses. Especially when night shift nurses patrol the ward, due to factors such as light and fatigue, it is more likely to cause adverse events such as administration errors.
[0005] In addition, chemotherapy drugs are highly toxic and complex to administer, and long-term injection in the same part can easily lead to the formation of subcutaneous induration, and even cause skin redness, swelling, stinging pain and other reactions, which may cause skin ulceration in severe cases, causing physical and psychological distress to patients. Therefore, it is particularly important to rotate and accurately record the injection site.
[0006] In order to solve the above problems, an antitumor injection class drug dynamic monitoring card is designed. UTILITY MODEL CONTENT
[0007] In view of the problems existing in the prior art, the utility model provides an antitumor injection class drug dynamic monitoring card which can effectively record and rotate injection site, avoid administration errors and reduce adverse reactions of patients.
[0008] The utility model discloses a kind of antitumor injection drug dynamic monitoring cards, it is characterized in that, including a substrate, the substrate is molded with protruding human profile part, at least according to the injection point of one injection class tumor drug treatment regimen on human profile part, injection point protruding part that can be pressed and sunken is equipped;
[0009] Injection process recording area is further provided with an injection process recording protruding part for recording injection days and / or injection needle times in a treatment cycle on the substrate;
[0010] Patient information card insertion slot and injection date recording part are provided on the substrate.
[0011] Further preferably, injection point protruding part and injection process recording protruding part are integrally molded with the substrate.
[0012] Further preferably, through holes are provided on injection point of human profile part and injection process recording area, and elastic plastic injection point protruding part and injection process recording protruding part are connected in the through holes by adhesive or hot melt.
[0013] Further preferably, injection point protruding part and injection process recording protruding part are spherical protrusions, circles, squares or triangles.
[0014] Further preferably, tumor drug name guide part is provided on the substrate.
[0015] Further preferably, when injection class tumor drugs are two or more, injection point protruding part and injection process recording protruding part on injection point of treatment regimen are distinguished by color or shape, and tumor drug name guide part is consistent with corresponding injection point protruding part and injection process recording protruding part in color or shape.
[0016] Further preferably, a fluorescent layer is provided on the surface of the substrate or on the surface of injection point protruding part and injection process recording protruding part.
[0017] Further preferably, a waterproof film layer is provided on the outer surface of the substrate.
[0018] Further preferably, anti-slip texture or protrusions are provided on the surface of the substrate.
[0019] Further preferably, a hanging hole or a magnet is provided on the upper part of the substrate.
[0020] The utility model has the advantages and technical effects: the utility model designs a kind of antitumor injection drug dynamic monitoring cards, and its overall technical effect is remarkable, greatly improves the efficiency, accuracy and safety of clinical nursing work.
[0021] The monitoring card intuitively displays the human structure through the molded human contour part, so that nurses can quickly locate the injection site, and the accuracy and efficiency of injection are improved. The design of the injection site protruding part and the injection process record protruding part not only facilitates nurses to record the injection situation, but also effectively prevents repeated injection of the same part, reduces the occurrence of subcutaneous induration and skin adverse reactions. At the same time, the protruding parts have the function of being pressed reversely to restore the initial state, so that the monitoring card can be repeatedly used, and medical resources are saved.
[0022] The integrated molding design ensures the close combination of the protruding part and the substrate, improves the overall stability and durability of the monitoring card. The through-hole design and the use of elastic plastic material give the monitoring card higher flexibility and adaptability, facilitate the replacement or maintenance of the protruding part, and prolong the service life.
[0023] The injection site protruding part and the injection process record protruding part adopt diversified shape designs such as spherical, circular, square or triangular, which provide rich recording methods and enhance the visual recognition of the monitoring card. The setting of the tumor drug name guide part effectively records the drug name and injection dose, provides an intuitive drug guide for nurses, and avoids medication errors.
[0024] For the treatment situation of various tumor drugs, the injection site protruding part and the injection process record protruding part are clearly distinguished by color or shape, and an intuitive and clear drug guide system is constructed. This design greatly optimizes the operation process of nurses, reduces the risk of incorrect injection, and improves the efficiency and quality of nursing work.
[0025] In addition, the design of the fluorescent layer, the waterproof film layer and the hanging hole or the magnet further improves the practicality and convenience of the monitoring card. The fluorescent layer makes the injection site protruding part and the record protruding part clearly visible in dim environments, improving the accuracy and efficiency of identification. The waterproof film layer effectively prevents damage to the monitoring card caused by moisture or water splashing. The design of the hanging hole or the magnet allows the monitoring card to be conveniently hung or adsorbed on medical equipment or the work area, saving space and facilitating ready access.
[0026] The setting of the slide texture or the protrusion effectively improves the stability of the monitoring card during use, preventing recording errors or operational inconvenience caused by sliding or accidental touch.
[0027] In summary, the anti-tumor injection drug dynamic monitoring card of the utility model provides a more economical, efficient and safe solution for clinical nursing work with its excellent technical effect. BRIEF DESCRIPTION OF DRAWINGS
[0028] Figure 1 is a structural schematic diagram of an embodiment of the utility model;
[0029] Figure 2 and Figure 3 is the front and rear structure schematic diagram of the utility model;
[0030] Figure 4 is the both sides with anti-skid texture structure schematic diagram.
[0031] In the figure, 1, base plate; 101, human body contour part; 102, injection point position protruding part; 103, injection process record protruding part; 104, patient information card insertion slot; 105, tumor drug name guide part; 106, anti-skid texture; 107, hanging hole; 108, injection date record part. DETAILED DESCRIPTION
[0032] In order to make the utility model purposes, technical scheme and advantages more clearly, the following with examples, the utility model is further described in detail.It should be understood that the specific embodiments described herein are only used to explain the utility model, and are not used to limit the utility model.
[0033] Please refer to Figures 1 to 3 A kind of antitumor injection type drug dynamic monitoring card, including a base plate 1, the base plate is molded with protruding human body contour part 101, base plate as the basis of monitoring card, provides stable support;Molded human body contour part then directly shows human body structure, so that nurses can quickly locate injection site.This design improves the accuracy and efficiency of injection.At least according to the injection point position of one injection type tumor drug treatment regimen, injection point position protruding part 102 is provided on human body contour part;Injection point position protruding part arranged on injection point position can record injection condition by sinking after pressing.This way is intuitive and convenient, avoids the drawbacks that traditional paper record is easy to lose and easy to blur.At the same time, it can also effectively prevent the same part from being injected repeatedly, reduce the occurrence of subcutaneous induration and skin adverse reactions.
[0034] Injection process record protruding part 103 for recording injection days and / or injection needle times in treatment cycle is also provided on the injection process record area of base plate;This design allows nurses to record the number of injection days and / or needle times in treatment cycle, ensures the traceability of drug administration process.This helps to improve the standardization and safety of nursing work.
[0035] Patient information card insertion slot 104 and injection date record part 108 are provided on the base plate, patient information card insertion slot is used for inserting patient information card, the design of insertion slot facilitates quick acquisition and checking of patient information, reduces the risk of information error;Injection date record part 108 can be a card slot or groove with upper development four edges and the rest of the closed edges, and injection date record part is inserted with injection date card or uses double-sided adhesive tape to paste injection date card.
[0036] The anti-tumor injection drug dynamic monitoring card is extremely innovative in design, especially in the recording and management of injection points and injection processes. The injection point protrusions are accurately set according to specific tumor drug treatment protocols, ensuring accurate positioning of each injection. The injection process recording protrusions cleverly record the number of injection days and / or needle times during the treatment period, providing the medical team with a clear reference for the treatment progress.
[0037] More noteworthy is that these protrusions all have the function of restoring the original state by reverse pressing. When a treatment course is completed, the nurse only needs to simply reverse press the sunken protrusions, which can quickly rebound to the original state, making the monitoring card reusable. This design not only greatly saves medical resources, but also improves the convenience and efficiency of nursing work, providing a more economical and efficient solution for the continuous treatment of patients.
[0038] Further preferably, the injection point protrusions and the injection process recording protrusions are integrally molded with the substrate. First, this integrated design ensures the close combination of the protrusions and the substrate, improving the overall stability and durability of the monitoring card. Second, integrally molding the protrusions makes their positioning and shape more accurate, allowing nurses to feel clear feedback when pressing the records, thereby more accurately recording the injection points and injection processes. In addition, since the protrusions are integrally formed with the substrate, the risk of loose or damaged connections due to component separation is reduced, reducing the risk of recording errors or monitoring card failures due to component separation. This design also makes the monitoring card easy to clean and disinfect, meeting the hygiene standards for clinical use and improving its practicality and safety in a medical environment.
[0039] Further preferably, through holes are provided on the injection points of the human body contour part and the injection process recording area, and elastic plastic injection point protrusions and injection process recording protrusions are connected in the through holes by adhesive or hot melting. This scheme provides through holes on the injection points of the human body contour part and the injection process recording area, and connects elastic plastic injection point protrusions and injection process recording protrusions through adhesive or hot melting. This design gives the monitoring card higher flexibility and adaptability. The use of elastic plastic material makes the protrusions have better pressing feel and recovery, and the records remain clear even after long-term use. In addition, the through hole design facilitates the replacement or maintenance of the protrusions, prolonging the service life of the monitoring card. This modular design also facilitates individual customization according to treatment needs, improving the practicality of the monitoring card.
[0040] Further preferably, the injection point protrusions and injection process record protrusions are spherical protrusions, circles, squares, or triangles. Various recording methods are provided. These shapes facilitate nurses to press the records quickly and accurately, and also enhance the visual recognition of the monitoring card, improving the convenience and efficiency of clinical use.
[0041] Further preferably, the substrate is provided with a tumor drug name guide 105. The drug name and injection dose are effectively recorded, providing nurses with an intuitive drug guide. This not only avoids medication errors, but also improves the accuracy and efficiency of nursing work, ensuring the safety and therapeutic effect of patient medication.
[0042] Further preferably, when the injection type tumor drugs are two or more, the injection point protrusions and injection process record protrusions on the injection points of the treatment regimen are distinguished by color or shape, and the tumor drug name guide is consistent with the color or shape of the corresponding injection point protrusions and injection process record protrusions.
[0043] This embodiment ingeniously distinguishes the injection point protrusions and injection process record protrusions in the treatment regimen by color or shape for complex treatment situations where the injection type tumor drugs are two or more. Taking azacitidine and bortezomib as examples, the former, as a chemotherapy drug for treating acute myeloid leukemia, is represented by green (see Figure 1 double oblique slash), and its 4ml dose per time is injected in two parts within its 7-day or 9-day treatment cycle; while the latter, bortezomib, as a drug for treating multiple myeloma, is identified by red (see Figure 1 cross line), and its unique administration cycle and navel site injection method are self-evident.
[0044] The tumor drug name guide is consistent with the color or shape of the corresponding protrusions, constructing an intuitive and clear drug guide system. This design greatly optimizes the operation process of nurses in busy clinical work, significantly reducing the risk of incorrect injection caused by drug confusion. Nurses can quickly identify the injection points and recording methods of each drug by color or shape, ensuring accurate and error-free injection every time.
[0045] In addition, this consistent design not only improves the efficiency of nursing work, but also promotes seamless communication and efficient cooperation among medical teams, further improving the quality and safety of overall nursing work. For patients, this clear and intuitive drug guide undoubtedly enhances their trust and cooperation in the treatment process, adding more confidence and hope to the road to recovery from disease.
[0046] Further preferably, the surface of the substrate or the injection site protrusion and the injection process record protrusion surface is provided with a fluorescent layer. The fluorescent layer can emit bright light under light irradiation, so that the injection site protrusion and the record protrusion are clearly visible in a dim environment, greatly improving the accuracy and efficiency of the nurse's recognition in the night or insufficient light conditions. At the same time, the fluorescent layer also enhances the visual appeal of the monitoring card, facilitating the medical team to quickly identify and locate, further improving the safety and convenience of clinical nursing work.
[0047] Further preferably, the outer surface of the substrate is provided with a waterproof film layer. Effectively prevent the damage or information blur of the monitoring card caused by moisture or water splashing. The waterproof film layer improves the durability and reliability of the monitoring card, so that it can maintain stable use performance in various clinical environments. This design prolongs the service life of the monitoring card, reduces the medical cost, and also ensures the clearness of the recorded information, providing continuous and reliable support for nursing work.
[0048] Further preferably, the upper part of the substrate is provided with a hanging hole 107 or a magnet. So that the monitoring card can be conveniently hung or adsorbed on the medical equipment or working area, which not only saves space but also is convenient to use at any time. This design improves the practicability and convenience of the monitoring card in the clinical environment, so that the nurse can more efficiently manage and use the monitoring card, providing more smooth and orderly support for the treatment and nursing of patients.
[0049] Further preferably, please refer to Figure 4 , the surface of the substrate is provided with an anti-slip texture 106 or a protrusion. Effectively improve the stability of the monitoring card during use, prevent recording errors or operation inconvenience caused by sliding or accidental touch. The anti-slip design makes the nurse easily and stably hold and operate the monitoring card in the tense and busy clinical work, improves the work efficiency and accuracy, and provides a strong guarantee for the safe treatment of patients.
[0050] The above only describes the preferred embodiments of the present application, and does not limit the present application. Any modification, equivalent replacement and improvement made within the spirit and principle of the present application shall be included in the protection scope of the present application.
Claims
1. An antitumor injection drug dynamic monitoring card, characterized in that, The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate.
2. The anti-tumor injection type medicine dynamic monitoring card according to claim 1, characterized in that: The injection point convex part and the injection process record convex part are integrally molded with the substrate.
3. The dynamic monitoring card for anti-tumor injection drugs according to claim 1, characterized in that: The injection point convex part and the injection process record convex part are integrally molded with the substrate.
4. The dynamic monitoring card for anti-tumor injection drugs according to claim 1, characterized in that: The injection point convex part and the injection process record convex part are integrally molded with the substrate.
5. The dynamic monitoring card for anti-tumor injection drugs according to claim 1, characterized in that: The injection point convex part and the injection process record convex part are integrally molded with the substrate.
6. The dynamic monitoring card for anti-tumor injection drugs according to claim 5, characterized in that: The injection point convex part and the injection process record convex part are integrally molded with the substrate.
7. The dynamic monitoring card for anti-tumor injection drugs according to claim 1, characterized in that: The injection point convex part and the injection process record convex part are integrally molded with the substrate.
8. The dynamic monitoring card for anti-tumor injection drugs according to claim 1, characterized in that: The injection point convex part and the injection process record convex part are integrally molded with the substrate.
9. The dynamic monitoring card for anti-tumor injection drugs according to claim 1, characterized in that: The injection point convex part and the injection process record convex part are integrally molded with the substrate.
10. The dynamic monitoring card for anti-tumor injection drugs according to claim 1, characterized in that: The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record convex part are integrally molded with the substrate. The injection point convex part and the injection process record